Bluerock Therapeutics Email Format

Biotechnology Research
201-500 employees
Cambridge, MA, USA

BlueRock Therapeutics is a clinical-stage biotechnology company developing cellular medicines to treat neurological and ophthalmic diseases, operating as a subsidiary of Bayer AG.

Find contacts at Bluerock Therapeutics

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstinitiallast@bluerocktx.com

Company Overview

Industry
Biotechnology Research
Founded
2016
Headquarters
Cambridge, MA, USA
Revenue
$25M-$50M
FUNDING Stage
Subsidiary
Key Executives
Seth Ettenberg (President and CEO), Natasha Rathee (SVP, Global Head of Finance), Craig Beasley (Chief Technology Officer)

Tech Stack

Amazon Web Services (AWS)

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Bluerock Therapeutics?

Bluerock Therapeutics uses the firstinitiallast format on bluerocktx.com, so Jane Smith would be jsmith@bluerocktx.com.

What therapeutic areas does Bluerock Therapeutics focus its cell therapy programs on?

Bluerock Therapeutics focuses on neurology and ophthalmology, developing iPSC-based cell therapies for conditions like Parkinson's disease, inherited retinal disorders, and age-related macular degeneration.

How advanced is Bluerock Therapeutics' bemdaneprocel program for Parkinson's disease?

Bemdaneprocel is the most clinically advanced allogeneic pluripotent stem cell-derived therapy for Parkinson's disease in the US, and Bluerock Therapeutics advanced it into a Phase 3 registrational trial called exPDite-2 in January 2025.

Who leads Bluerock Therapeutics as its chief executive?

Seth Ettenberg serves as President and CEO of Bluerock Therapeutics, leading the company alongside CTO Craig Beasley and SVP of Global Finance Natasha Rathee from headquarters in Cambridge, MA.

Is Bluerock Therapeutics an independent company or a subsidiary?

Bluerock Therapeutics is a wholly owned subsidiary of Bayer AG, acquired in 2019, and operates independently from its Cambridge, MA headquarters with around 461 employees. You can use Clay to find and verify specific Bluerock Therapeutics contacts by role or department.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles